Pheochromocytoma medical therapy: Difference between revisions
| Line 7: | Line 7: | ||
Any surgical option requires prior treatment with both the non-specific alpha adrenoceptor blocker [[phenoxybenzamine]] to counteract hypertension and the beta-1 adrenoceptor antagonist [[atenolol]] to reduce cardiac output. Given before surgery, these can also block the effect of a sudden release of adrenaline during tumour removal, which would otherwise endanger the anaethetised patient. | Any surgical option requires prior treatment with both the non-specific alpha adrenoceptor blocker [[phenoxybenzamine]] to counteract hypertension and the beta-1 adrenoceptor antagonist [[atenolol]] to reduce cardiac output. Given before surgery, these can also block the effect of a sudden release of adrenaline during tumour removal, which would otherwise endanger the anaethetised patient. | ||
===Contraindicated medications=== | |||
{{MedCondContrAbs | |||
|MedCond =pheochromocytoma|Atomoxetine}} | |||
==References== | ==References== | ||
Revision as of 16:06, 8 September 2014
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma medical therapy |
|
Risk calculators and risk factors for Pheochromocytoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Any surgical option requires prior treatment with both the non-specific alpha adrenoceptor blocker phenoxybenzamine to counteract hypertension and the beta-1 adrenoceptor antagonist atenolol to reduce cardiac output. Given before surgery, these can also block the effect of a sudden release of adrenaline during tumour removal, which would otherwise endanger the anaethetised patient.
Contraindicated medications
pheochromocytoma is considered an absolute contraindication to the use of the following medications: